CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 1, 1995, Pages 41-45

  Yanagawa, Tatsuo ^a   Hidaka, Yoh ^a   Maraes, Valeria Gui ^a   Soliman, Mosaad ^a   Degroot, Leslie J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HLA A1 ANTIGEN; HLA ANTIGEN CLASS 2; HLA B7 ANTIGEN; HLA DQ ANTIGEN; THYROTROPIN RECEPTOR;

ALLELE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CAUCASIAN; CHROMOSOME 2Q; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HLA SYSTEM; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CAUCASOID RACE; FEMALE; GENE FREQUENCY; GENES; GENOTYPE; GRAVES' DISEASE; HLA ANTIGENS; HUMAN; MALE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; POLYMORPHISM (GENETICS); SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028873470     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.1.7829637     Document Type: Article

References (37)

1. DeGroot LJ, Quintans J. 1989 The causes of autoimmune thyroid disease. Endocr Rev. 10: 537-562.
2. Mckenzie JM, Zakarija M. 1988 Hyperthyroidism. In: DeGroot LJ, Besser GM, Cahill GF, eds. Endocrinology, 2nd ed. Philadel phia: Saunders; 646-682.
3. Volpe R. 1991 Graves´ disease. In: Braverman LE, Utiger RD, eds. The thyroid, 6th ed. Philadelphia: Lippincott; 648-657.
4. Mangklabruks A, Cox N, DeGroot LJ. 1991 Genetic factors in au toimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab. 73: 236-244.
5. Weetman AP, So AK, Roe C, Walport MJ, Foroni L. 1987 T Cell receptor β chain V region polymorphism linked to primary auto immune hypothyroidism but not Graves´ disease. Hum Immunol. 20: 167-173.
6. Demaine A, Welsh KI, Hawe BS, Farid NR. 1987 Polymorphism of the T cell receptor β-chain in Graves´ disease. J Clin Endocrinol Metab. 65: 643-646.
7. Demaine A, Welsh KI, Flawe BS, Farid NR. 1987 Polymorphism of the immunoglobulin heavy chain T cell receptor β-chain genes in Graves´disease. Acta Endocrinol (Copenh). 281: 149-151.
8. Uno H, Sasazuki T, Tamai H, Matsumoto H. 1981 Two major genes, linked to HLA and Gm, control susceptibility to Graves´ disease. Nature. 292: 768-770.
9. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. 1992 Genetics of autoimmune thyroid disease: lack of evidence for link age to HLA within families. J Clin Endocrinol Metab. 74: 496-503.
10. Cox NJ, Xiang KS, Fajans SS, Bell GI. 1992 Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes. 41: 401-407.
11. Botstein D, White RL, Skolnick M, Davis RW. 1980 Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet. 32: 314-331.
12. NIH/CEPH Collaborative Mapping Group. 1992 A comprehensive genetic linkage map of the human genome. Science. 258: 148-162.
13. McLachlan SM. 1993 Editorial: the genetic basis of autoimmune thyroid disease: time to focus on chromosomal loci other than the major histocompatibility complex (HLA in man). J Clin Endocrinol Metab. 77: 605A-605C.
14. Buonavista N, Balzano C, Pontarotti P, Le Paslier D, Golstein P. 1992 Molecular linkage of the human CTLA4 and CD28 Ig-super-family genes in yeast artificial chromosomes. Genomics. 13: 856-861.
15. Lenschow DJ, Bluestone JA. 1993 T Cell co-stimulation and in vwo tolerance. Curr Opin Immunol. 5: 747-752.
16. Dariavach P, Mattei MG, Golstein P, Lefranc MP. 1988 Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. EurJ Immunol. 18: 1901-1905.
17. Yanagawa T, Mangklabruks A, Chang YB, 1993 Human histocompatibility leukocyte antigen-DQAl*0501 allele associated with genetic susceptibility to Graves´disease in a Caucasian pop ulation. J Clin Endocrinol Metab. 76: 1569-1574.
18. Yanagawa T, Mangklabruks A, DeGroot LJ. 1994 Strong associa tion between HLA-DQA1*0501 and Graves´ disease in a male Cau casian population. J Clin Endocrinol Metab. 79: 227-229.
19. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. 1991 Dinucle otide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res. 19: 4018.
20. Payami H, Joe S, Farid NR, 1989 Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves’ disease. Am J Hum Genet. 45: 541-546.
21. Woolf B. 1955 On estimating the relation between blood group and disease. Ann Hum Genet. 19: 251-253.
22. Lee TD, Lee G, Zhao TM, HLA-DR, DQ antigens in North American Caucasians. Tissue Antigens. 35: 64-70.
23. Badenhoop K, Schwarz G, Shleusener H, 1992 Tumor necrosis factor β gene polymorphism in Graves´ disease. J Clin Endocrinol Metab. 74: 287-291.
24. Ratanachaiyavong S, Gunn CA, Bidwell EA, Darke C, Hall R, McGregor AM. 1990 DQA2U allele: a genetic marker for relapse of Graves´disease. Clin Endocrinol (Oxf). 32: 241-251.
25. Allannic H, Fauchet R, Lorcy Y, et al. 1980 HLA and Graves´ disease: an association with HLA-DRw3. J Clin Endocrinol Metab. 51: 863-867.
26. Okamoto Y, Yanagawa T, Fisfalen ME, DeGroot LJ. 1994 Prolif erative responses of peripheral blood mononuclear cells from pa tients with Graves´ disease to synthetic peptides epitopes of human thyrotropin receptor. Thyroid. 4: 37-42.
27. Ahmad MF, Stenszky V, Juhazs F, Balazs G, Farid NR. 1994 No mutations in the translated region of exon 1 in the TSH receptor in Graves´ thyroid glands. Thyroid. 4: 151-153.
28. June CH, Ledbetter JA, Linsley PS, Thompson CB. 1990 Role of the CD28 receptor in T-cell activation. Immunol Today. 11: 211-216.
29. Koulova L, Clark EA, Shu G, Dupont B. 1991 The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4 T cells. J Exp Med. 173: 759-762.
30. De Boer M, Kasran A, Kwekkeboom J, Walter H, Vandenberghe P, Ceuppens JL. 1993 Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and effi cient help for antibody production by B cells. Eur J Immunol. 23: 3120-3125.
31. Linsley PS, Greene JL, Tan P, 1992 Coexpression and func tional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med. 176: 1595-1604.
32. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. 1991 CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol. 147: 1037-1044.
33. Shaw G, Kamen R. 1986 A conserved AU sequence from the 3´ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46: 659-667.
34. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. 1994 Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
35. Yeo PPB, Chan SH, Thai AC, 1989 HLA Bw46 and DR9 associations in Graves´ disease of Chinese patients are age-and sex-related. Tissue Antigen. 34: 179-184.
36. Cavan DA, Penny MA, Jacobs KH, 1994 The HLA association with Graves´ disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol (Oxf). 40: 63-66.
37. Ahmed SA, Penhale WJ, Talal N. 1985 Sex hormones, immune responses, and autoimmune diseases. Am J Pathol. 121: 531-551.